These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8393136)

  • 1. Evidence that the middle T antigen of polyomavirus interacts with the membrane skeleton.
    Andrews DW; Gupta J; Abisdris G
    Mol Cell Biol; 1993 Aug; 13(8):4703-13. PubMed ID: 8393136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane association of polyomavirus middle-T antigen in an in vitro system.
    Hofer U; Wehrle B; Ballmer-Hofer K
    Virus Res; 1995 Feb; 35(2):169-80. PubMed ID: 7762290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimerization of polyomavirus middle-T antigen.
    Senften M; Dilworth S; Ballmer-Hofer K
    J Virol; 1997 Sep; 71(9):6990-5. PubMed ID: 9261428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cytoskeletal organization in polyoma middle T antigen-transformed fibroblasts: involvement of protein phosphatase 2A and src tyrosine kinases.
    da Costa SR; Wang Y; Vilalta PM; Schönthal AH; Hamm-Alvarez SF
    Cell Motil Cytoskeleton; 2000 Dec; 47(4):253-68. PubMed ID: 11093247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cytoskeletal association by a basic amino acid motif in polyoma virus middle T antigen.
    Elliott J; Jones MD; Griffin BE; Krauzewicz N
    Oncogene; 1998 Oct; 17(14):1797-806. PubMed ID: 9778045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of p53 and p105-RB is not sufficient for oncogenic transformation by a hybrid polyomavirus-simian virus 40 large T antigen.
    Manfredi JJ; Prives C
    J Virol; 1990 Nov; 64(11):5250-9. PubMed ID: 2214017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase.
    Ulug ET; Cartwright AJ; Courtneidge SA
    J Virol; 1992 Mar; 66(3):1458-67. PubMed ID: 1371166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyomavirus middle-T antigen lacking a membrane anchor sequence accumulates in the nucleus.
    Messerschmitt A; Disela C; Dilworth S; Marti AG; Ballmer-Hofer K
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():17-26. PubMed ID: 8558125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyomavirus large T-antigen binds the "pRb related' protein p130 through sequences in conserved region 2.
    Desjardins P; Pilon AA; Hassell JA; Mes-Masson AM
    Virus Res; 1997 Jan; 47(1):85-90. PubMed ID: 9037740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At the onset of transformation polyomavirus middle-T recruits shc and src to a perinuclear compartment coincident with condensation of endosomes.
    Zhu W; Eicher A; Leber B; Andrews DW
    Oncogene; 1998 Aug; 17(5):565-76. PubMed ID: 9704922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequences flanking the pentanucleotide T-antigen binding sites in the polyomavirus core origin help determine selectivity of DNA replication.
    Li L; Li BL; Hock M; Wang E; Folk WR
    J Virol; 1995 Dec; 69(12):7570-8. PubMed ID: 7494263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An SV40 mutant oncoprotein has a nuclear location.
    Sompayrac L; Danna KJ
    Virology; 1989 Jul; 171(1):267-70. PubMed ID: 2741344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.
    Denis D; Rouleau C; Schaffhausen BS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27852846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector.
    Davidson D; Hassell JA
    J Virol; 1987 Apr; 61(4):1226-39. PubMed ID: 3029418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker.
    Algrain M; Turunen O; Vaheri A; Louvard D; Arpin M
    J Cell Biol; 1993 Jan; 120(1):129-39. PubMed ID: 8416983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation.
    Utermark T; Schaffhausen BS; Roberts TM; Zhao JJ
    J Virol; 2007 Jul; 81(13):7069-76. PubMed ID: 17442716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated forms of the polyomavirus middle T antigen can substitute for the small T antigen in lytic infection.
    Templeton D; Simon S; Eckhart W
    J Virol; 1986 Jan; 57(1):367-70. PubMed ID: 3001358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N terminus of hamster polyomavirus middle T antigen carries a determinant for specific activation of p59c-Fyn.
    Goutebroze L; Dunant NM; Ballmer-Hofer K; Feunteun J
    J Virol; 1997 Feb; 71(2):1436-42. PubMed ID: 8995669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of large T-antigen-binding site A, but not site B or C, eliminates stalling by RNA polymerase II in the intergenic region of polyomavirus DNA.
    Bertin J; Sunstrom NA; Acheson NH
    J Virol; 1993 Oct; 67(10):5766-75. PubMed ID: 8396655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.